![Kevin Heller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Kevin N.
Heller worked as Senior Medical Director at AstraZeneca PLC from 2013 to 2015.
He served as VP & Head-Antibody Clinical Development at Incyte Corp.
from 2015 to 2018.
He was Chief Medical Officer at NextCure, Inc. from 2018 to 2020.
He held the position of Executive Vice President-Research & Development at Jasper Therapeutics, Inc. from 2021 to 2022.
Dr. Heller earned a doctorate from George Washington University and completed undergraduate studies at Yale University.
Former positions of Kevin Heller
| Companies | Position | End |
|---|---|---|
| JASPER THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-03-16 |
| NEXTCURE, INC. | Chief Tech/Sci/R&D Officer | 2020-08-03 |
| INCYTE CORPORATION | Corporate Officer/Principal | 2018-03-31 |
| ASTRAZENECA PLC | Chief Tech/Sci/R&D Officer | 2015-04-30 |
Training of Kevin Heller
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
73
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
George Washington University
 George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NextCure, Inc.
 NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
Jasper Therapeutics, Inc.
 Jasper Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Health Technology |
- Stock Market
- Insiders
- Kevin Heller
